posted on 2023-12-13, 16:41authored byQi Zhou, Pablo Catalán, Helen Bell, Patrick Baumann, Rebekah Cooke, Rhodri Evans, Jianhua Yang, Zhen Zhang, Davide Zappalà, Ye Zhang, George Michael Blackburn, Yuan He, Yi Jin
Antibiotic-resistant Enterobacterales that produce
oxacillinase (OXA)-48-like Class D β-lactamases are often linked
to increased clinical mortality. Though the catalytic mechanism of
OXA-48 is known, the molecular origin of its biphasic kinetics has
been elusive. We here identify selective chloride binding rather than
decarbamylation of the carbamylated lysine as the source of biphasic
kinetics, utilizing isothermal titration calorimetry (ITC) to monitor
the complete reaction course with the OXA-48 variant having a chemically
stable N-acetyl lysine. Further structural investigation
enables us to capture an unprecedented inactive acyl intermediate
wedged in place by a halide ion paired with a conserved active site
arginine. Supported by mutagenesis and mathematical simulation, we
identify chloride as a “Janus effector” that operates
by allosteric activation of the burst phase and by inhibition of the
steady state in kinetic assays of β-lactams. We show that chloride-induced
biphasic kinetics directly affects antibiotic efficacy and facilitates
the differentiation of clinical isolates encoding Class D from Class
A and B carbapenemases. As chloride is present in laboratory and clinical
procedures, our discovery greatly expands the roles of chloride in
modulating enzyme catalysis and highlights its potential impact on
the pharmacokinetics and efficacy of antibiotics during in
vivo treatment.